Home >> Industry News >> Hologic’s test for SARS-CoV-2 receives EUA

Hologic’s test for SARS-CoV-2 receives EUA

image_pdfCreate PDF

“Early diagnosis of the coronavirus is critical both to managing infected patients and to mitigating the spread of the disease,” Maurice Exner, vice president of research and development and clinical affairs at Hologic, said in a press release. “The EUA for our SARS-CoV-2 assay on the Panther Fusion system allows laboratories to run many more tests per day than they can on manual systems, enhancing the public health fight.”

Hologic expects to provide its laboratory customers with tens of thousands of SARS-CoV-2 tests this month and expects to produce nearly 600,000 SARS-CoV-2 tests a month starting in April.

CAP TODAY
X